wider

Robotics & AI

“Announcement: Meta’s Highly Anticipated Llama 3 LLM Will Soon Be Available as an Open-Source Release”

“Our goal over time is to make a Llama-powered Meta AI be the most useful assistant in the world,” said Joelle Pineau, Vice President AI Research. Most notably, Meta’s Llama families, built as open-source products, represent a different philosophical approach to how AI should develop as a wider technology. But Meta is also playing it more cautiously, it seems, especially when it comes to other generative AI beyond text generation. Ironically — or perhaps predictably (heh) — even as Meta works to launch Llama 3, it does have some significant generative AI skeptics in the house. It’s not generative AI,” he said.

Ava Patel
April 9, 2024
1 Comment

Robotics & AI

5 Shows Potential: Reddit’s IPO Triumph Rests on AI Growth

The long-running dearth of IPOs could be coming to a close, partly due to Reddit’s upcoming public debut. Expected to list this month, Reddit saw its valuation soar during the pandemic. If Reddit’s IPO does well, it could wiggle open the public-offering window just a little bit wider than we’ve seen in quarters and quarters. Of course, the public offering could also fizzle out like an unpopular opinion downvoted to hell on the site. But with an AI-friendly growth story to tell, Reddit may have timed its ramp towards the public markets just right.

Zara Khan
March 12, 2024

Uncategorized

Revolutionary Skincare: SynFlora’s Pursuit of Bioengineering

Biotech startup SynFlora brought an enticing pitch for a new type of skin treatment technology to 4YFN at the MWC tradeshow in Barcelona this week. The Spanish startup, whose three co-founders all have PhDs, is working to improve understanding of the skin’s microbiome and engineer skin microbes with the goal of enabling more targeted and novel therapeutics. Including things that range well beyond what we might consider skincare. ), per Knōdlseder, or even vaccines and anti-inflammatory treatments. But the co-founders suggest they could be between one to three years away from their novel system powering a new generation of skin-delivered therapeutics.